Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse nerve growth factor injection for children with global developmental delay
ChiCTR2200063635Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of mouse nerve growth factor in Global Developmental Delay (GDD) (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Griffiths Developmental Assessment Scale-Chinese Version (GDS-C). Started Aug 2022; status: recruiting.
02
Drugs
mouse nerve growth factor
03
Conditions
Global Developmental Delay (GDD)
Beyond the preview
Go deeper on ChiCTR2200063635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063635.